Medical Equipment

Renal Denervation Devices Market Insights: Revenue Expected to Surpass $2.27 Billion by 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the renal denervation devices market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Renal Denervation Devices Market?

The renal denervation devices market has seen substantial growth in recent years. This market is expected to expand from $0.55 billion in 2024 to $0.74 billion in 2025, achieving a compound annual growth rate (CAGR) of 33.1%. The growth observed in prior periods is linked to several factors, including an increase in hypertension cases, extensive clinical research and studies, a rise in cardiovascular diseases, initial FDA approvals and other regulatory advancements, and the introduction of renal denervation systems into the market.

The renal denervation devices market is set for significant expansion over the next few years. It is projected to reach $2.27 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 32.5%. This anticipated growth during the forecast period is primarily due to a patient-centric approach, advancements in healthcare infrastructure, increasing awareness and acceptance, a strong emphasis on minimally invasive therapies, and the introduction of new devices into the market. Key trends expected in the forecast period include the integration of artificial intelligence (ai) and machine learning, changes in the regulatory landscape, a shift towards minimally invasive procedures, an increased focus on clinical evidence, and the adoption of remote monitoring and telehealth integration.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10631&type=smp

Which Growth Drivers Are Propelling The Renal Denervation Devices Market?

The escalating prevalence of hypertension is anticipated to propel the future expansion of the renal denervation devices market. Hypertension, also known as high blood pressure, is a condition where the force of blood within the vessels remains consistently elevated. Renal denervation, a catheter-based intervention, has emerged as a viable therapeutic approach for patients with resistant hypertension. It is a minimally invasive, investigational technique employed to treat hypertension that has not responded to medication. For instance, in May 2024, data from the Centers for Disease Control and Prevention, a US-based government agency, revealed that in 2022, high blood pressure contributed to or directly resulted in 685,875 deaths in the United States. Hence, the rising incidence of hypertension will foster the growth of the renal denervation devices market.

Which Segmentation Factors Are Most Significant In The Renal Denervation Devices Market Analysis?

The renal denervation devicesmarket covered in this report is segmented –

1) By Product: Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, Other Products

2) By Technology: Radio Frequency Ablation, Ultrasound Energy-Based RDN, Brachytherapy, Chemical Ablation, Other Technologies

3) By End-Users: Hospitals, Cardiovascular research centre, Other End-Users

Subsegments:

1) By Simplicity Renal Denervation System: Catheter System, Accessories

2) By EnligHTN: Catheter System, Generator, Accessories

3) By Vessix Renal Denervation System: Balloon Catheter, Generator, Accessories

4) By Iberis Renal Sympathetic Denervation System: Catheter System, Accessories

5) By Paradise Renal Denervation System: Catheter System, Accessories

6) By Other Products: Emerging Technologies, Alternative Devices

What New Opportunities Are Emerging From Trends In The Renal Denervation Devices Market?

Leading companies in the renal denervation devices market are concentrating on developing ultrasound renal denervation (uRDN) technology. Their aim is to improve the effectiveness of treatments, minimize complications during procedures, and offer a non-invasive option compared to conventional renal denervation methods. This uRDN technology enhances renal denervation devices by allowing for accurate, non-invasive delivery of energy to the renal nerves. This approach efficiently lowers blood pressure while simultaneously safeguarding surrounding tissues, thereby increasing patient safety and comfort throughout the procedure. An example of this advancement occurred in November 2023, when Recor Medical Inc., a medical technology firm based in the US, introduced its Paradise uRDN system. This innovative ultrasound renal denervation device is specifically engineered to manage hypertension in individuals whose blood pressure targets have not been met through conventional lifestyle adjustments and pharmaceutical interventions. Equipped with hydrocooling technology to protect the renal artery during the treatment process, this system marks a notable progression within the renal denervation devices market. It provides a novel, non-pharmacological method for addressing resistant hypertension and broadens the range of available treatment options for patients.

Who Are The Most Influential Companies In The Renal Denervation Devices Market?

Major companies operating in the renal denervation devices market include Medtronic PLC, ReCor Medical Inc., Boston Scientific Corporation, Abbott Laboratories, Cordis Corporation, Terumo Corporation, Kona Medical Inc., St. Jude Medical LLC, Johnson & Johnson, Mercator MedSystems Inc., Symple Surgical Inc., Ablative Solutions Inc., Cardiosonic Ltd., Renal Dynamics Ltd., Vesalio LLC, Atricure Inc., Biosense Webster Inc., Biotronik SE & Co. KG, Cook Medical LLC, Hansen Medical Inc., Merit Medical Systems Inc., AngioDynamics Inc., Covidien Ltd., Volcano Corporation, Edwards Lifesciences Corporation, InnoVein Inc., Teleflex Incorporated, Medinol Ltd., Oscor Inc., Balton Sp. z o.o.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/renal-denervation-devices-global-market-report

Which Region Holds The Largest Share In The Renal Denervation Devices Market Today?

Europe was the largest region in the renal denervation devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global renal denervation devices market report during the forecast period. The regions covered in the renal denervation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10631&type=smp

Browse Through More Reports Similar to the Global Renal Denervation Devices Market 2025, By The Business Research Company

Blood Pressure Monitoring Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-pressure-monitoring-devices-global-market-report

Wearable Blood Pressure Monitors Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wearable-blood-pressure-monitors-global-market-report

Pulmonary Arterial Hypertension Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pulmonary-arterial-hypertension-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795